The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer
Open accessAbstract
CONTEXT: Comparative reviews of whole-body magnetic resonance imaging (WB-MRI) and positron emission tomography/computed tomography (CT; with different radiotracers) have shown that metastasis detection in advanced cancers is more accurate than with currently used CT and bone scans. However, the ability of WB-MRI and positron emission tomography/CT to assess therapeutic benefits has not been comprehensively evaluated. There is also considerable variability in the availability and quality of WB-MRI, which is an impediment to clinical development. Expert recommendations for standardising WB-MRI scans are needed, in order to assess its performance in advanced prostate cancer (APC) clinical trials. OBJECTIVE: To design recommendations that promote standardisation and diminish variations in the acquisition, interpretation, and reporting of WB-MRI scans for use in APC. EVIDENCE ACQUISITION: An international expert panel of oncologic imagers and oncologists with clinical and research interests in APC management assessed biomarker requirements for clinical care and clinical trials. Key requirements for a workable WB-MRI protocol, achievable quality standards, and interpretation criteria were identified and synthesised in a white paper. EVIDENCE SYNTHESIS: The METastasis Reporting and Data System for Prostate Cancer guidelines were formulated for use in all oncologic manifestations of APC. CONCLUSIONS: Uniformity in imaging data acquisition, quality, and interpretation of WB-MRI are essential for assessing the test performance of WB-MRI. The METastasis Reporting and Data System for Prostate Cancer standard requires validation in clinical trials of treatment approaches in APC. PATIENT SUMMARY: METastasis Reporting and Data System for Prostate Cancer represents the consensus recommendations on the performance, quality standards, and reporting of whole-body magnetic resonance imaging, for use in all oncologic manifestations of advanced prostate cancer. These new criteria require validation in clinical trials of established and new treatment approaches in advanced prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Abiraterone and Increased Survival in Metastatic Prostate Cancer
de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407 · cited 1×
“[28]; Beer et al.”
Integrative Clinical Genomics of Advanced Prostate Cancer
Robinson, D., Van Allen, E. M., Wu, Y.-M., Schultz, N., Lonigro, R. J., Mosquera, J.-M., Montgomery, B., Taplin, M.-E., Pritchard, C. C., Attard, G., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.001 · Cited by 3,645
Self-citationAlpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213755 · Cited by 3,408
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Beer, T. M., Armstrong, A. J., Rathkopf, D. E., Loriot, Y., Sternberg, C. N., Higano, C. S., Iversen, P., Bhattacharya, S., Carles, J., Chowdhury, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1405095 · Cited by 3,028
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Sweeney, C. J., Chen, Y.-H., Carducci, M., Liu, G., Jarrard, D. F., Eisenberger, M., Wong, Y.-N., Hahn, N., Kohli, M., Cooney, M. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503747 · Cited by 2,896
James, N. D., Sydes, M. R., Clarke, N. W., Mason, M. D., Dearnaley, D. P., Spears, M. R., Ritchie, A. W. S., Parker, C. C., Russell, J. M., Attard, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01037-5 · Cited by 1,978
Self-citationScher, H. I., Morris, M. J., Stadler, W. M., Higano, C., Basch, E., Fizazi, K., Antonarakis, E. S., Beer, T. M., Carducci, M. A., Chi, K. N., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.2702 · Cited by 1,654
Self-citationRyan, C. J., Smith, M. R., Fizazi, K., Saad, F., Mulders, P. F. A., Sternberg, C. N., Miller, K., Logothetis, C. J., Shore, N. D., Small, E. J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71205-7 · Cited by 1,369 · cited 1×
“[31]; Evans et al.”
Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
Aparicio, A. M., Harzstark, A. L., Corn, P. G., Wen, S., Araujo, J. C., Tu, S.-M., Pagliaro, L. C., Kim, J., Millikan, R. E., Ryan, C., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3791 · Cited by 479
Halabi, S., Lin, C.-Y., Kelly, W. K., Fizazi, K. S., Moul, J. W., Kaplan, E. B., Morris, M. J., & Small, E. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.3696 · Cited by 478
Halabi, S., Kelly, W. K., Ma, H., Zhou, H., Solomon, N. C., Fizazi, K., Tangen, C. M., Rosenthal, M., Petrylak, D. P., Hussain, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.7270 · Cited by 461
Shen, G., Deng, H., Hu, S., & Jia, Z. (2014) · Skeletal Radiology · doi:10.1007/s00256-014-1903-9 · Cited by 363
Gillessen, S., Omlin, A., Attard, G., de Bono, J. S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv257 · Cited by 322
Self-citationCastration-Resistant Prostate Cancer: AUA Guideline
Cookson, M. S., Roth, B. J., Dahm, P., Engstrom, C., Freedland, S. J., Hussain, M., Lin, D. W., Lowrance, W. T., Murad, M. H., Oh, W. K., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.05.005 · Cited by 275
Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets
Chi, K. N., Bjartell, A., Dearnaley, D., Saad, F., Schröder, F. H., Sternberg, C., Tombal, B., & Visakorpi, T. (2009) · European Urology · doi:10.1016/j.eururo.2009.06.027 · Cited by 253
Sabbatini, P., Larson, S. M., Kremer, A., Zhang, Z.-F., Sun, M., Yeung, H., Imbriaco, M., Horak, I., Conolly, M., Ding, C., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.948 · Cited by 237
Diffusion‐weighted imaging outside the brain: Consensus statement from an ISMRM‐sponsored workshop
Taouli, B., Beer, A. J., Chenevert, T., Collins, D., Lehman, C., Matos, C., Padhani, A. R., Rosenkrantz, A. B., Shukla‐Dave, A., Sigmund, E., et al. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25196 · Cited by 175
Self-citationKoh, D.-M., Blackledge, M., Collins, D. J., Padhani, A. R., Wallace, T., Wilton, B., Taylor, N. J., Stirling, J. J., Sinha, R., Walicke, P., et al. (2009) · European Radiology · doi:10.1007/s00330-009-1469-4 · Cited by 163
Self-citationFitzpatrick, J. M., Joaquim Bellmunt, B., Fizazi, K. S., Heidenreich, A., Sternberg, C. N., TOMBAL, B. F., Alcaraz, A., Bahl, A. K., Sergio Bracarda, A., Lorenzo, G. D., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.03.010 · Cited by 156
Self-citationCastration-Resistant Prostate Cancer: From New Pathophysiology to New Treatment
Sridhar, S. S., Freedland, S. J., Gleave, M. E., Higano, C. S., Mulders, P., Parker, C. C., Sartor, O. A., & Fred Saad, C. (2013) · European Urology · doi:10.1016/j.eururo.2013.08.008 · Cited by 152
Morris, M. J., Molina, A., Small, E. J., Bono, J. S. D., Logothetis, C. J., Fizazi, K. S., SOUZA, P. D., Kantoff, P. W., Higano, C. S., Li, J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.3875 · Cited by 145
Targeting bone metastases in prostate cancer: improving clinical outcome
Body, J., Casimiro, S., & Costa, L. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.90 · Cited by 132
Evans, C. P., Higano, C. S., Keane, T. E., Andriole, G. L., Fred Saad, C., Iversen, P., Miller, K., Kim, C., Kimura, G., Armstrong, A. J., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.03.017 · Cited by 102
Rationale for Modernising Imaging in Advanced Prostate Cancer
Padhani, A. R., Lecouvet, F. E., Tunariu, N., Koh, D., Keyzer, F. D., Collins, D. J., Sala, E., Fanti, S., Vargas, H. A., Petralia, G., et al. (2016) · European Urology Focus · doi:10.1016/j.euf.2016.06.018 · Cited by 98
Self-citationTOMBAL, B. F., Rezazadeh, A., Therasse, P., Cangh, P. J. V., Berg, B. V., & Lecouvet, F. E. (2005) · The Prostate · doi:10.1002/pros.20280 · Cited by 87
Self-citationProgress in emerging therapies for advanced prostate cancer
Oudard, S. M. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.09.005 · Cited by 81
Spritzer, C. E., Afonso, P. D., Vinson, E. N., Turnbull, J. D., Morris, K. K., Foye, A., Madden, J. F., Choudhury, K. R., Febbo, P. G., & George, D. J. (2013) · Radiology · doi:10.1148/radiol.13121782 · Cited by 64
Pérez-López, R., Lorente, D., Blackledge, M., Collins, D. J., Mateo, J., Bianchini, D., Omlin, A. G., Zivi, A., Leach, M. O., Bono, J. S. D., et al. (2016) · Radiology · doi:10.1148/radiol.2015150799 · Cited by 61
Self-citationLiu, L., Cui, L., Zhang, X., Cao, J., Chang, N., Tang, X., Qi, S., Zhang, X., Yin, H. J., & Zhang, J. (2015) · Medicine · doi:10.1097/md.0000000000001998 · Cited by 45
Tait, C. D., Moore, D., Hodgson, C., Brown, M. D., Morris, T., Growcott, J., Malone, M. D., Hughes, A. M., Renehan, A. G., Clarke, N. W., et al. (2014) · British Journal of Urology · doi:10.1111/bju.12717 · Cited by 38
Cited by
The Lancet Commission on prostate cancer: planning for the surge in cases
James, N. D., Tannock, I., N'Dow, J., Feng, F., Gillessen, S., Ali, S. A., Trujillo, B., Al-Lazikani, B., Attard, G., Bray, F., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00651-2 · Cited by 738
Self-citationGillessen, S., Attard, G., Beer, T. M., Beltran, H., Bossi, A., Bristow, R., Carver, B., Castellano, D., Chung, B. H., Clarke, N., et al. (2018) · European Urology · doi:10.1016/j.eururo.2017.06.002 · Cited by 642
Self-citationColeman, R. E., Croucher, P. I., Padhani, A. R., Clézardin, P., Chow, E., Fallon, M., Guise, T., Colangeli, S., Capanna, R., & Costa, L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00216-3 · Cited by 570
Self-citationMessiou, C., Hillengass, J., Delorme, S., Lecouvet, F. E., Moulopoulos, L. A., Collins, D. J., Blackledge, M. D., Abildgaard, N., Østergaard, B., Schlemmer, H.-P., et al. (2019) · Radiology · doi:10.1148/radiol.2019181949 · Cited by 328
Self-citation
Metadata
- Authors
- Padhani, A. R., Lecouvet, F. E., Tunariu, N., Koh, D.-M., De Keyzer, F., Collins, D. J., Sala, E., Schlemmer, H. P., Petralia, G., Vargas, H. A., Fanti, S., Tombal, H. B., & de Bono, J.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 71
- Issue
- 1
- Pages
- 81-92
- ISSN
- 0302-2838 (ISSN-L)
- OpenAlex
- W2423859833
- Cited by
- 333
- References
- 31
- FWCI
- 21.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.